InvestorsHub Logo

DonDonDonDon

05/25/21 1:52 PM

#167693 RE: BBalls-N-CowTown #167691

So they are giving up to 4 doses once a week with all of them being 700mg intravenously instead of the first dose of 700mg intravenously and 3 doses of 350mg subcutaneously?

MelsDollars

05/25/21 1:53 PM

#167694 RE: BBalls-N-CowTown #167691

Love that link Bballs! Saving lives in Brazil!! Yes sir!!

Looks like they are getting it done.

Up to 4 doses via IV and 1:1 ratio

daemon57

05/25/21 1:57 PM

#167695 RE: BBalls-N-CowTown #167691

Was waiting for this. And extremely happy as an investor that it's 4 doses AS IT WAS SUPPOSED TO BE for CD12. Thanks for posting this. Made my day.

GLTU/A.

Monroe1

05/25/21 1:59 PM

#167697 RE: BBalls-N-CowTown #167691

Bout damn time! Brazil is doing it right, the way our derelict FDA should have done it. This study is going to kick some lazy USA FDA ass from one goal post to the next.
Arm Intervention/treatment
Experimental: Leronlimab (700 mg)
Leronlimab 700 mg intravenously once a week (up to 4 doses) until hospital discharge
Drug: Leronlimab
Leronlimab 700 mg

Placebo Comparator: Placebo
Placebo intravenously once a week (up to 4 doses) until hospital discharge

Evil Rabbit

05/25/21 2:01 PM

#167699 RE: BBalls-N-CowTown #167691

Awesome news. Eff the coup. Let’s focus on Brazil and crushing the PE.

justdafactss

05/25/21 2:03 PM

#167701 RE: BBalls-N-CowTown #167691

But but but antibiotics cure pneumonia correct?

Condition or disease- COVID-19 Pneumonia
https://www.clinicaltrials.gov/ct2/show/NCT04901689

Now its throttled down to pneumonia???

Previously it was Coronavirus Disease 2019 correct?

Coronavirus Disease 2019
https://www.clinicaltrials.gov/ct2/show/NCT04347239?term=leronlimab&draw=3&rank=7

misiu143

05/25/21 2:17 PM

#167707 RE: BBalls-N-CowTown #167691

Thank you BBalls-N-CowTown. Thank you very much..

so protocol for severe patients ..

306 patients , drug to placebo 1:1 ratio.

Up to 4 doses , all IV infusion , or until hospital discharge ,
-this part I don't like to much , since some may need another SC dose after the discharge , but hopefully this will not happen.

---Primary endpoint , time of recovery , with some subgroups..
---secondary endpoints.
..clinical recovery days 14, 28,42,60
..All cause mortality at day 14, 28, 42 , and 60

Hopefully enrollment will start soon..

tikotiko

05/25/21 2:24 PM

#167713 RE: BBalls-N-CowTown #167691

It finally looks like a properly designed. It includes the 4 weekly IV doses and I bet it will be filled a lot sooner than some think.
Thank you Bballs!

Pctwst

05/25/21 3:50 PM

#167760 RE: BBalls-N-CowTown #167691

Well that is fantastic news. Thanks BBalls for sharing. It appears to me that this trial is designed for success.